A Novel MRI Biomarker for Incipient Alzheimer's Disease
A Novel MRI Biomarker for Incipient Alzheimer's Disease
批准号:
7537155
负责人:
Michael D Greicius
金额:
$17.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-12-15 至 2009-11-30
关键词:
AffectAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAreaBehavioralBiological MarkersBiological Neural NetworksBrain regionCerebrospinal FluidClinicalClinical ResearchClinical TrialsCognition DisordersCognitiveControl GroupsDementiaDiagnosisDiseaseDisease ProgressionDrug DesignEarly DiagnosisElderlyEpidemiologic StudiesEvaluationFunctional ImagingFunctional Magnetic Resonance ImagingGenderGoalsHippocampus (Brain)ImageIndividualInferiorLate Onset Alzheimer DiseaseMagnetic Resonance ImagingMentored Patient-Oriented Research Career Development AwardMentorsMetricNeurologyNeuropsychologyParietal LobePatientsPerformancePopulationPopulation StudyPrevalencePreventiveResearchResearch PersonnelResearch Project GrantsResearch TrainingRestRiskSerumTechniquesUnited Statesbasecareer developmentcingulate cortexcomputer programmental statemild neurocognitive impairmentneural patterningneuroimagingneuropsychologicalnovelpatient orientedpatient oriented researchpreventprogramsskillsstatistics
中文摘要
描述(由申请人提供):这个指导以患者为导向的研究职业发展(K23)奖的长期目标是发展候选人的技能,将功能成像应用于以患者为导向的临床研究,使他成为痴呆症和神经影像学领域的独立研究者。Greicius博士的具体研究目标是发展神经影像技术应用于阿尔茨海默病(AD)早期和准确诊断的熟练程度。为了实现这一目标,候选人将由功能成像,衰老和认知障碍,神经心理学和统计学领域的专家指导。此外,候选人将继续学习教育课程,包括行为神经学和功能成像方面的高级研讨会,以及计算机编程,神经心理学和统计学领域的正式课程。最后,候选人将承担一个与他的研究培训计划紧密结合的研究项目。
拟议研究项目的目标是开发一种新的fMRI技术,该技术将以高度的确定性预测哪些有AD风险的受试者随后将发展为该疾病。该研究将使用一种新的fMRI方法,功能连接MRI(fcMRI),检查三个受试者组:轻度认知障碍(MCI)组,轻度-中度AD组,以及一组年龄和性别与AD和MCI组受试者匹配的健康老年人。MCI组将在基线时进行成像,并进行纵向临床和神经心理学评价。功能连接分析将集中在一个特定的静息状态网络(RSN),其中包括几个大脑区域受影响的早期过程中的AD,包括后扣带皮层(PCC),下顶叶和海马。主要假设是:1)功能连接分析将证明与年龄匹配的对照组相比,AD组的RSN活性异常,2)RSN活性异常将可靠地区分转化为AD的MCI患者与未转化为AD的MCI患者。
通过开展这项研究项目和实施研究培训计划,Greicius博士计划成为痴呆症和神经影像学领域的独立研究者,并为早期发现和治疗AD和其他老年痴呆症做出贡献。
英文摘要
DESCRIPTION (provided by applicant): The long-term objective of this Mentored Patient-Oriented Research Career Development (K23) Award is to develop the candidate's skills in applying functional imaging to patient-oriented clinical research so that he may become an independent investigator in the fields of dementia and neuroimaging. Dr. Greicius' specific research goal is to develop proficiency in the application of neuroimaging techniques to the early and accurate diagnosis of Alzheimer's disease (AD). To accomplish this goal, the candidate will be mentored by experts in the fields of functional imaging, aging and cognitive disorders, neuropsychology and statistics. In addition, the candidate will pursue an educational program to include advanced seminars in behavioral neurology and functional imaging as well as formal coursework in the areas of computer programming, neuropsychology and statistics. Finally, the candidate will undertake a research project closely aligned with his research training plan.
The goal of the proposed research project is to develop a novel fMRI technique that will predict, with a high degree of certainty, which subjects at risk for AD will subsequently develop the disease. The study will use a novel fMRI approach, functional connectivity MRI (fcMRI), to examine three subject groups: A group with mild cognitive impairment (MCI), a group with mild-moderate AD, and a group of healthy older adults age- and gender-matched to subjects in the AD and MCI groups. The MCI group will be imaged at baseline and followed longitudinally with clinical and neuropsychological evaluations. The functional connectivity analysis will focus on a specific resting-state network (RSN) that incorporates several brain regions affected early in the course of AD including the posterior cingulate cortex (PCC), inferior parietal lobes, and hippocampus. The main hypotheses are that 1) functional connectivity analyses will demonstrate abnormal RSN activity in the AD group compared to age-matched controls and 2) abnormal activity in the RSN will reliably distinguish MCI patients who convert to AD from those MCI patients who do not.
By conducting this research project and implementing the research training plan, Dr. Greicius plans to become an independent investigator in the fields of dementia and neuroimaging and contribute to the early detection and treatment of AD and other dementing diseases of the elderly.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pcbi.1000100
发表时间:
2008-06-27
期刊:
PLOS COMPUTATIONAL BIOLOGY
影响因子:
4.3
作者:
[Supekar, Kaustubh, Menon, Vinod, Rubin, Daniel, Musen, Mark, Greicius, Michael D.]
通讯作者:
Greicius, Michael D.
DOI:
10.1523/jneurosci.1868-09.2009
发表时间:
2009-07-01
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
[Habas C, Kamdar N, Nguyen D, Prater K, Beckmann CF, Menon V, Greicius MD]
通讯作者:
Greicius MD
Illuminating the APOE Locus with Long-Read Sequencing and Targeted Genomics
-
批准号:10640191
-
项目类别:
-
资助金额:$92.25万
-
财政年份:2021
-
负责人:Michael D Greicius
-
依托单位:
Illuminating the APOE Locus with Long-Read Sequencing and Targeted Genomics
-
批准号:10477987
-
项目类别:
-
资助金额:$93.24万
-
财政年份:2021
-
负责人:Michael D Greicius
-
依托单位:
Illuminating the APOE Locus with Long-Read Sequencing and Targeted Genomics
-
批准号:10208579
-
项目类别:
-
资助金额:$94.42万
-
财政年份:2021
-
负责人:Michael D Greicius
-
依托单位:
The Stanford Extreme Phenotypes in Alzheimer's Disease (StEP AD) Cohort
-
批准号:10431761
-
项目类别:
-
资助金额:$24.37万
-
财政年份:2018
-
负责人:Michael D Greicius
-
依托单位:
The Stanford Extreme Phenotypes in Alzheimer's Disease (StEP AD) Cohort
-
批准号:10225285
-
项目类别:
-
资助金额:$75.44万
-
财政年份:2018
-
负责人:Michael D Greicius
-
依托单位:
Development of Resting-State fMRI as a Biomarker for Alzheimers Disease
-
批准号:8664451
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2010
-
负责人:Michael D Greicius
-
依托单位:
A NOVEL FMRI BIOMARKER OF INCIPIENT ALZHEIMER?S DISEASE
-
批准号:8169828
-
项目类别:
-
资助金额:$1.85万
-
财政年份:2010
-
负责人:Michael D Greicius
-
依托单位:
Development of Resting-State fMRI as a Biomarker for Alzheimers Disease
-
批准号:8465920
-
项目类别:
-
资助金额:$43.49万
-
财政年份:2010
-
负责人:Michael D Greicius
-
依托单位:
Development of Resting-State fMRI as a Biomarker for Alzheimers Disease
-
批准号:8090273
-
项目类别:
-
资助金额:$44.79万
-
财政年份:2010
-
负责人:Michael D Greicius
-
依托单位:
Development of Resting-State fMRI as a Biomarker for Alzheimers Disease
-
批准号:8257556
-
项目类别:
-
资助金额:$44.41万
-
财政年份:2010
-
负责人:Michael D Greicius
-
依托单位:
Development of Resting-State fMRI as a Biomarker for Alzheimers Disease
-
批准号:7899707
-
项目类别:
-
资助金额:$47.67万
-
财政年份:2010
-
负责人:Michael D Greicius
-
依托单位:
A NOVEL FMRI BIOMARKER OF INCIPIENT ALZHEIMER?S DISEASE
-
批准号:7955354
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2009
-
负责人:Michael D Greicius
-
依托单位:
A NOVEL FMRI BIOMARKER OF INCIPIENT ALZHEIMER?S DISEASE
-
批准号:7722868
-
项目类别:
-
资助金额:$1.12万
-
财政年份:2008
-
负责人:Michael D Greicius
-
依托单位:
A NOVEL FMRI BIOMARKER OF INCIPIENT ALZHEIMER?S DISEASE
-
批准号:7601880
-
项目类别:
-
资助金额:$1.15万
-
财政年份:2007
-
负责人:Michael D Greicius
-
依托单位:
A NOVEL FMRI BIOMARKER OF INCIPIENT ALZHEIMER?S DISEASE
-
批准号:7358760
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2006
-
负责人:Michael D Greicius
-
依托单位:
A Novel MRI Biomarker for Incipient Alzheimer's Disease
-
批准号:7158576
-
项目类别:
-
资助金额:$17.37万
-
财政年份:2004
-
负责人:Michael D Greicius
-
依托单位:
A Novel MRI Biomarker for Incipient Alzheimer's Disease
-
批准号:6990564
-
项目类别:
-
资助金额:$17.37万
-
财政年份:2004
-
负责人:Michael D Greicius
-
依托单位:
A Novel MRI Biomarker for Incipient Alzheimer's Disease
-
批准号:7339679
-
项目类别:
-
资助金额:$17.37万
-
财政年份:2004
-
负责人:Michael D Greicius
-
依托单位:
A Novel MRI Biomarker for Incipient Alzheimer's Disease
-
批准号:6866002
-
项目类别:
-
资助金额:$17.37万
-
财政年份:2004
-
负责人:Michael D Greicius
-
依托单位:
Imaging Core
-
批准号:9922036
-
项目类别:
-
资助金额:$35.53万
-
财政年份:--
-
负责人:Michael D Greicius
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: